Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.64% | -10.45% | -5.17% | -8.87% | -19.13% |
| Total Depreciation and Amortization | 4.61% | 9.90% | 1.84% | 10.19% | 5.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.23% | -64.74% | 215.14% | -3,031.48% | 98.04% |
| Change in Net Operating Assets | 908.86% | -40.92% | 77.87% | 144.72% | -257.21% |
| Cash from Operations | 5.45% | -23.34% | 15.01% | -0.02% | -11.15% |
| Capital Expenditure | 75.10% | 65.67% | 51.70% | -1,029.90% | 84.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.66% | -10,589.06% | -147.17% | -- | -- |
| Cash from Investing | -4.62% | -761.20% | 42.68% | -932.54% | -101.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30,671.43% | 100.65% | 87.24% | -1,225.51% | -105.74% |
| Cash from Financing | -33,985.71% | 100.62% | -100.43% | 45,518.65% | -101.03% |
| Foreign Exchange rate Adjustments | -1,128.07% | 98.10% | -168.68% | 1,159.65% | 130.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.19% | -53.95% | -120.08% | 588.34% | -217.58% |